RxAnte CEO Josh Benner speaks on connecting real-world evidence to value-based contract design and execution

April 24, 2018

RxAnte President and CEO Josh Benner took the podium at the AMCP Annual Meeting in Boston today, speaking on how leveraging real-world evidence (RWE) is critical to move the market forward in value-based contracting (VBC).

In today’s value-focused healthcare environment, health plans and pharmaceutical manufacturers have a shared interest in getting more value from medicines, but there are still significant barriers to accelerated market growth in the VBC space:

For health plans, this includes a lack of resources and technology infrastructure to manage a new contracting approach such as VBC, along with a need for clearer line of sight into how their member populations will fare on specific therapies from a health outcomes perspective. Pharmaceutical manufacturers are challenged by the need for additional personnel and infrastructure to manage multiple VBCs concurrently, a limited ability to improve performance at the member level, and the need for VBC outcomes to remain focused on what is on the product’s label and born out in clinical trials.

The talk featured a case study on RxAnte’s work with UPMC Health Plan, where RxAnte facilitated the collection and analysis of RWE in order to inform how VBCs should be designed and executed. Stay tuned for a recap of our week at AMCP, featuring key takeaways from our discussion on value-based contracting.

Contact us today or stop by booth #713 at AMCP to learn more about how RxAnte is helping health plans and manufacturers collaborate on RWE work to inform both quality improvement programs and value-based contracts.

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.